Furthermore, we observed that ECRG4 expression was positively correlated with OGN, which is a tumor suppressor in colorectal cancer and breast cancer (Hu et al., 2018; Xu et al., 2019). This evidence concerns the gene ECRG4 and breast carcinoma.